186 related articles for article (PubMed ID: 4302987)
1. Estrogens in the menopause and postmenopause.
Rogers J
N Engl J Med; 1969 Feb; 280(7):364-7. PubMed ID: 4302987
[No Abstract] [Full Text] [Related]
2. Managing the menopause.
Easterling WE
Am Fam Physician; 1973 Mar; 7(3):137-42. PubMed ID: 4348388
[No Abstract] [Full Text] [Related]
3. [Treatment of the preclimacteric and climacteric with a new estrogen-progestin association].
Goisis M
Minerva Ginecol; 1969 Feb; 21(4):193-7. PubMed ID: 5402123
[No Abstract] [Full Text] [Related]
4. [Modern trends in substitutive estrogen therapy in the postmenopausal period. B. Results of the use of an estro-progestogenic association].
Bubani V; Sansa G
Ann Ostet Ginecol Med Perinat; 1968 Jul; 90(7):453-96. PubMed ID: 5712636
[No Abstract] [Full Text] [Related]
5. HORMONES AND THE MENOPAUSE.
BENDER S
Practitioner; 1964 Mar; 192():359-62. PubMed ID: 14130831
[No Abstract] [Full Text] [Related]
6. The role of estrogens in osteoporosis.
Gordan GS; Vaughan C
Geriatrics; 1977 Sep; 32(9):42-8. PubMed ID: 885348
[No Abstract] [Full Text] [Related]
7. Estrogens for the menopause. Maximizing benefits, minimizing risks.
Seller JC
Postgrad Med; 1977 Sep; 62(3):73-9. PubMed ID: 197509
[TBL] [Abstract][Full Text] [Related]
8. Estrogen replacement therapy.
Alcoff JM
Am Fam Physician; 1982 Jun; 25(6):183-6. PubMed ID: 6282102
[No Abstract] [Full Text] [Related]
9. [Management of hirsutism using cyproterone acetate].
Hammerstein J; Cupceancu B
Dtsch Med Wochenschr; 1969 Apr; 94(16):829-34. PubMed ID: 4304873
[No Abstract] [Full Text] [Related]
10. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
[TBL] [Abstract][Full Text] [Related]
11. Management of the menopause.
Studd J
Practitioner; 1976 May; 216(1295):546-9. PubMed ID: 181743
[No Abstract] [Full Text] [Related]
12. [Are estrogens contraindicated in breast carcinoma?].
Gabius S; Blossey HC; Teichmann A; Nagel GA
Dtsch Med Wochenschr; 1988 Nov; 113(45):1774-8. PubMed ID: 2846255
[No Abstract] [Full Text] [Related]
13. Post menopausal bleeding related to estrogen therapy. An increasing problem.
Copenhaver EH
Geriatrics; 1968 Nov; 23(11):128-30. PubMed ID: 4301353
[No Abstract] [Full Text] [Related]
14. Management of the cervical factor in infertility.
Moghissi KS
J Reprod Med; 1977 Mar; 18(3):163-4. PubMed ID: 192890
[No Abstract] [Full Text] [Related]
15. The climacteric.
Zussman L
Proc R Soc Med; 1973 Feb; 66(2):183-5. PubMed ID: 4351701
[No Abstract] [Full Text] [Related]
16. The climacteric and some of its problems.
Goldfarb AF
Geriatrics; 1969 May; 24(5):107-16. PubMed ID: 5769661
[No Abstract] [Full Text] [Related]
17. Continuous cyclic hormonal therapy.
Rhoades FP
J Am Geriatr Soc; 1974 Apr; 22(4):183-5. PubMed ID: 4361730
[No Abstract] [Full Text] [Related]
18. [Comparison of the osteoprotective effects of orally administered equine conjugated estrogens and percutaneous 17 beta-estradiol].
Reginster JY; Sarlet N; Deroisy R; Denis D; Lecart MP; Franchimont P
Rev Med Liege; 1989 Jan; 44(2):55-60. PubMed ID: 2538905
[No Abstract] [Full Text] [Related]
19. [Developmental trends and conformities in the hormone therapy of climacteric disorders].
Buschbeck H
Med Klin; 1967 Sep; 62(37):1432-7. PubMed ID: 4298778
[No Abstract] [Full Text] [Related]
20. Post-menopausal osteoporosis and estrogens. Who should be treated and why.
Saville PD
Postgrad Med; 1984 Feb; 75(2):135-8, 142-3. PubMed ID: 6320148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
